MedTrace Logo

Severe Immune Cytopenia Registry Www.Sic-reg.Org

NCT03576742 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-11-21

No results posted yet for this study

Summary

Prospective registry study for children and young adults with severe immune cytopenias (persisting/chronic immune thrombocytopenia, autoimmune hemolytic anemia, and Evans syndrome) to improve the management, facilitate the differential diagnostic work-up, and document the clinical course under various treatments.

Time points: at inclusion, after 6 months, after 12 months, then yearly up to 4 years after inclusion.

No intervention, mere observation and documentation. Guided pre-inclusion (differential) diagnostic work-up.

Conditions

Interventions

DIAGNOSTIC_TEST

potential biomarkers

facs analysis, microbiome analysis

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Seidel · Medical University of Graz

Eligibility

Min Age
6 Months
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-09
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03576742 on ClinicalTrials.gov